Dilshat Djumanov, Director of Data Science at Richmond Pharmacology explores how GDPR is central to protecting private information. From clinical research to patient monitoring, the collection and sharing of data is key, as outlined by Dilshat Djumanov, Director of Data Science at Richmond Pharmacology. In their PM Live article published today, Djumonov explores how GDPR is central to protecting private information while presenting unique challenges to the pharmaceutical clinical trials industry. The post Brexit control of critical data and the ability to share information adds to the complexity with the UK planning its own reforms under the Data Reform Bill.

These regulatory changes, and other in the various frameworks around the world, are helping the integration of data management tools and realise the potential benefit for both industry and patients of better data-sharing tools. Unlocking the next generation of data sharing, processing and visualisation in clinical trials will be the next great frontier in pharmaceuticals. Medical privacy has been at the core of trial participation for a long time and the clinical research industry is perhaps the most advanced in understanding how to safely handle sensitive personal data.

Latest news

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read more

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Latest news

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read more

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event